Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review

Danazol is a treatment option for autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Three patients with AIHA and eight patients with ITP between 2008 and 2022 were enrolled in the Rheumatology Outpatient Clinic of Chang Gung Memorial Hospital, Kaohsiung. Those patients were refra...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Hsu-En Huang, Ko-Ming Lin, Jing-Chi Lin, Yu-Ting Lin, Hsiao-Ru He, Yu-Wei Wang, Shan-Fu Yu, Jia-Feng Chen, Tien-Tsai Cheng
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Subjects:	danazol autoimmune hemolytic anemia immune thrombocytopenia
Online Access:	https://www.mdpi.com/1424-8247/15/11/1377